331 related articles for article (PubMed ID: 31792094)
1.
Lee YC; Chung CP; Chang MH; Wang SJ; Liao YC
Neurology; 2020 Jan; 94(1):e87-e96. PubMed ID: 31792094
[TBL] [Abstract][Full Text] [Related]
2. The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank.
Lin E; Kuo PH; Liu YL; Wang TJ; Yang AC; Tsai SJ
J Neurol; 2023 Nov; 270(11):5536-5544. PubMed ID: 37526664
[TBL] [Abstract][Full Text] [Related]
3. Broad phenotype of cysteine-altering
Rutten JW; Hack RJ; Duering M; Gravesteijn G; Dauwerse JG; Overzier M; van den Akker EB; Slagboom E; Holstege H; Nho K; Saykin A; Dichgans M; Malik R; Lesnik Oberstein SAJ
Neurology; 2020 Sep; 95(13):e1835-e1843. PubMed ID: 32732295
[TBL] [Abstract][Full Text] [Related]
4. Modifiable vascular risk factors contribute to stroke in 1080
Lin HJ; Chen CH; Su MW; Lin CW; Cheng YW; Tang SC; Jeng JS
Int J Stroke; 2024 Jan; 19(1):105-113. PubMed ID: 37485895
[TBL] [Abstract][Full Text] [Related]
5. Cysteine-Altering
Hack RJ; Rutten JW; Person TN; Li J; Khan A; Griessenauer CJ; ; Abedi V; Lesnik Oberstein SAJ; Zand R
Stroke; 2020 Dec; 51(12):3562-3569. PubMed ID: 33161844
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical characteristics of stroke patients with p.R544C
Tang SC; Chen YR; Chi NF; Chen CH; Cheng YW; Hsieh FI; Hsieh YC; Yeh HL; Sung PS; Hu CJ; Chern CM; Lin HJ; Lien LM; Peng GS; Chiou HY; Jeng JS
Ann Clin Transl Neurol; 2019 Jan; 6(1):121-128. PubMed ID: 30656190
[TBL] [Abstract][Full Text] [Related]
7.
Cho BPH; Nannoni S; Harshfield EL; Tozer D; Gräf S; Bell S; Markus HS
J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):694-701. PubMed ID: 33712516
[TBL] [Abstract][Full Text] [Related]
8. Imaging-based pregenetic screening for NOTCH3 p.R544C mutation in ischemic stroke in Taiwan.
Cheng YW; Chen CH; Hu CJ; Chiou HY; Tang SC; Jeng JS
Ann Clin Transl Neurol; 2020 Oct; 7(10):1951-1961. PubMed ID: 32929895
[TBL] [Abstract][Full Text] [Related]
9. Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations.
Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
PLoS One; 2020; 15(6):e0234797. PubMed ID: 32555735
[TBL] [Abstract][Full Text] [Related]
10. Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction.
Hack RJ; Gravesteijn G; Cerfontaine MN; Santcroos MA; Gatti L; Kopczak A; Bersano A; Duering M; Rutten JW; Lesnik Oberstein SAJ
Brain; 2023 Jul; 146(7):2913-2927. PubMed ID: 36535904
[TBL] [Abstract][Full Text] [Related]
11. A Japanese CADASIL patient with homozygous NOTCH3 p.Arg544Cys mutation confirmed pathologically.
Mukai M; Mizuta I; Ueda A; Nakashima D; Kushimura Y; Noto YI; Ohara T; Itoh K; Ando Y; Mizuno T
J Neurol Sci; 2018 Nov; 394():38-40. PubMed ID: 30199759
[No Abstract] [Full Text] [Related]
12. Genotype-phenotype correlations of cysteine replacement in CADASIL.
Matsushima T; Conedera S; Tanaka R; Li Y; Yoshino H; Funayama M; Ikeda A; Hosaka Y; Okuzumi A; Shimada Y; Yamashiro K; Motoi Y; Nishioka K; Hattori N
Neurobiol Aging; 2017 Feb; 50():169.e7-169.e14. PubMed ID: 27890607
[TBL] [Abstract][Full Text] [Related]
13. New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Abramycheva N; Stepanova M; Kalashnikova L; Zakharova M; Maximova M; Tanashyan M; Lagoda O; Fedotova E; Klyushnikov S; Konovalov R; Sakharova A; Illarioshkin S
J Neurol Sci; 2015 Feb; 349(1-2):196-201. PubMed ID: 25623805
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.
Liao YC; Hsiao CT; Fuh JL; Chern CM; Lee WJ; Guo YC; Wang SJ; Lee IH; Liu YT; Wang YF; Chang FC; Chang MH; Soong BW; Lee YC
PLoS One; 2015; 10(8):e0136501. PubMed ID: 26308724
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients.
Gravesteijn G; Dauwerse JG; Overzier M; Brouwer G; Hegeman I; Mulder AA; Baas F; Kruit MC; Terwindt GM; van Duinen SG; Jost CR; Aartsma-Rus A; Lesnik Oberstein SAJ; Rutten JW
Hum Mol Genet; 2020 Jul; 29(11):1853-1863. PubMed ID: 31960911
[TBL] [Abstract][Full Text] [Related]
16. Association of
Cho BPH; Jolly AA; Nannoni S; Tozer D; Bell S; Markus HS
Neurology; 2022 Aug; 99(5):e430-e439. PubMed ID: 35641310
[TBL] [Abstract][Full Text] [Related]
17. Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese.
Lee YC; Liu CS; Chang MH; Lin KP; Fuh JL; Lu YC; Liu YF; Soong BW
J Neurol; 2009 Feb; 256(2):249-55. PubMed ID: 19242647
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations and effect of mutation location in Japanese CADASIL patients.
Mukai M; Mizuta I; Watanabe-Hosomi A; Koizumi T; Matsuura J; Hamano A; Tomimoto H; Mizuno T
J Hum Genet; 2020 Aug; 65(8):637-646. PubMed ID: 32277177
[TBL] [Abstract][Full Text] [Related]
19. CADASIL.
Wang MM
Handb Clin Neurol; 2018; 148():733-743. PubMed ID: 29478611
[TBL] [Abstract][Full Text] [Related]
20. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) associated with a novel C82R mutation in the NOTCH3 gene.
Zea-Sevilla MA; Bermejo-Velasco P; Serrano-Heranz R; Calero M
J Alzheimers Dis; 2015; 43(2):363-7. PubMed ID: 25096610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
